FR2422407A1 - Matiere cicatrisante facilitant la cicatrisation des blessures - Google Patents

Matiere cicatrisante facilitant la cicatrisation des blessures

Info

Publication number
FR2422407A1
FR2422407A1 FR7909340A FR7909340A FR2422407A1 FR 2422407 A1 FR2422407 A1 FR 2422407A1 FR 7909340 A FR7909340 A FR 7909340A FR 7909340 A FR7909340 A FR 7909340A FR 2422407 A1 FR2422407 A1 FR 2422407A1
Authority
FR
France
Prior art keywords
healing
injuries
material facilitating
healing material
facilitating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7909340A
Other languages
English (en)
French (fr)
Other versions
FR2422407B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unitika Ltd
Original Assignee
Unitika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP53043466A external-priority patent/JPS6054069B2/ja
Priority claimed from JP13111678A external-priority patent/JPS5558163A/ja
Application filed by Unitika Ltd filed Critical Unitika Ltd
Publication of FR2422407A1 publication Critical patent/FR2422407A1/fr
Application granted granted Critical
Publication of FR2422407B1 publication Critical patent/FR2422407B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7909340A 1978-04-12 1979-04-12 Matiere cicatrisante facilitant la cicatrisation des blessures Granted FR2422407A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53043466A JPS6054069B2 (ja) 1978-04-12 1978-04-12 新しい創傷部保護材料
JP13111678A JPS5558163A (en) 1978-10-24 1978-10-24 Material for treating wounded portion

Publications (2)

Publication Number Publication Date
FR2422407A1 true FR2422407A1 (fr) 1979-11-09
FR2422407B1 FR2422407B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-12-17

Family

ID=26383228

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7909340A Granted FR2422407A1 (fr) 1978-04-12 1979-04-12 Matiere cicatrisante facilitant la cicatrisation des blessures

Country Status (4)

Country Link
US (1) US4265233A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2914822A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2422407A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2023614B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448901A1 (fr) * 1979-02-15 1980-09-12 Immuno Ag Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle
FR2448900A1 (fr) * 1979-02-15 1980-09-12 Immuno Ag Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle
EP0023607A3 (en) * 1979-07-19 1981-04-15 Behringwerke Aktiengesellschaft Process for preparing a collagen solution, such a solution and its use
FR2485375A1 (fr) * 1980-06-30 1981-12-31 Applied Med Devices Composition coagulante utilisable comme pansement et utilisation sous forme de produit preconditionne
FR2500304A1 (fr) * 1981-02-24 1982-08-27 Human Oltoanyagtermelo Materiau de recouvrement de plaie et son procede de fabrication
EP0090997A3 (en) * 1982-04-02 1985-10-30 Dr. Ruhland Nachf. Gmbh Adhesive wound covering material comprising collagen
EP0172710A3 (en) * 1984-08-09 1987-08-12 Unitika Ltd. Hemostatic agent
WO1990013320A1 (en) * 1989-05-05 1990-11-15 Ferrosan A/S Haemostatic sponge
EP0509041A4 (en) * 1990-01-03 1993-10-13 Cryolife, Inc Fibrin sealant delivery method
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
WO1994022470A1 (en) * 1993-03-30 1994-10-13 Hoechst Japan Limited Factor xiii for treatment of skin wounds

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
US4767619A (en) * 1981-09-14 1988-08-30 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Burn wound dressing material
DE3139089A1 (de) * 1981-10-01 1983-04-14 Röhm Pharma GmbH, 6100 Darmstadt Flaechengebilde auf proteinbasis als traeger therapeutisch wirksamer, nicht-immobilisierter enzyme
EP0086627B1 (en) * 1982-02-12 1985-08-28 Unitika Ltd. Anti-cancer device
DE3214337C2 (de) * 1982-04-19 1984-04-26 Serapharm - Michael Stroetmann, 4400 Münster Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
CA1202904A (en) * 1983-11-21 1986-04-08 Brian G. Sparkes Chitosan based wound dressing materials
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
US4659572A (en) * 1985-04-15 1987-04-21 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Burn wound dressing material
WO1986007541A1 (en) * 1985-06-19 1986-12-31 Yasushi Zyo Composition which can impart antithrombotic ability and medical apparatus to be in contact with blood
US5112608A (en) * 1987-03-13 1992-05-12 Incyte Pharmaceuticals Use of protease nexin-I to mediate wound healing
US5278049A (en) * 1986-06-03 1994-01-11 Incyte Pharmaceuticals, Inc. Recombinant molecule encoding human protease nexin
US5206017A (en) * 1986-06-03 1993-04-27 Incyte Pharmaceuticals, Inc. Use of protease nexin-I as an antiinflammatory
US5196196A (en) * 1986-06-03 1993-03-23 Incyte Pharmaceuticals, Inc. Use of protease nexin-I in wound dressings
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
US5384125A (en) * 1987-03-31 1995-01-24 Water-Jel Technologies, Inc. Burn dressing
WO1989001512A1 (en) * 1987-08-17 1989-02-23 The Liposome Company, Inc. A sponge enzyme having transglutaminase-like activity
AT407834B (de) * 1987-10-08 2001-06-25 Aventis Behring Gmbh Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
US4920158A (en) * 1989-10-11 1990-04-24 Medipro Sciences Limited Hydrogel-forming wound dressing or skin coating material
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
JPH02277886A (ja) * 1989-04-17 1990-11-14 Shigesaburo Mizushima ヒブロイン蛋白による合成繊維及び植物繊維の加工方法
US5271943A (en) * 1989-10-27 1993-12-21 Scott Health Care Wound gel compositions containing sodium chloride and method of using them
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US7189410B1 (en) 1990-11-27 2007-03-13 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
DE69218677T2 (de) * 1991-01-17 1997-11-13 Water Jel Tech Inc Brandwundenverband mit teebaumöl
WO1993004732A1 (en) 1991-09-09 1993-03-18 The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Methods and devices for treating hemophilia and aids
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
DK83092D0 (da) * 1992-06-24 1992-06-24 Unes As Fremgangsmaade til udvinding af thrombin
ES2139729T3 (es) * 1992-11-12 2000-02-16 Zymogenetics Inc Uso del factor xiii aplicado topicamente para la inhibicion de hemorragias.
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
US5660857A (en) * 1993-03-22 1997-08-26 Johnson & Johnson Medical Inc. Biopolymer composites
US5795780A (en) * 1993-06-23 1998-08-18 Bristol-Myers Squibb Company Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes
WO1995012371A1 (en) * 1993-11-03 1995-05-11 Clarion Pharmaceuticals, Inc. Hemostatic patch
US5505952A (en) * 1994-04-19 1996-04-09 United States Surgical Corporation Modified synthetic cross-linked amino acid polymers and medical devices formed therefrom
US5660854A (en) * 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
US5643192A (en) * 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
WO1996040033A1 (en) * 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US6033719A (en) * 1996-04-25 2000-03-07 Medtronic, Inc. Method for covalent attachment of biomolecules to surfaces of medical devices
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US6159232A (en) 1997-12-16 2000-12-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6478808B2 (en) 1997-12-17 2002-11-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
US6187347B1 (en) 2000-02-09 2001-02-13 Ecosafe, Llc. Composition for arresting the flow of blood and method
JP3576063B2 (ja) * 2000-02-22 2004-10-13 株式会社ホギメディカル 凝固蛋白質を含む可溶性創傷治癒止血セルロース繊維とその製造方法
EP1259269B1 (en) * 2000-03-03 2008-06-18 Syntacoll AG Agent for the treatment of wounds
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
US6648911B1 (en) 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
US7041868B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Bioabsorbable wound dressing
US7011965B2 (en) * 2001-03-09 2006-03-14 Regents Of The University Of Minnesota Compositions and methods for stimulating wound healing and fibroblast proliferation
WO2002091965A1 (en) * 2001-05-16 2002-11-21 Susanna Elizabeth Chalmers Wound dressings and wound treatment compositions
DE10135507A1 (de) * 2001-07-20 2003-02-06 Henkel Kgaa Blutstillendes Hautpflaster
CA2460023A1 (en) * 2001-09-10 2003-03-20 Zymogenetics, Inc. Method for treating coumarin-induced hemorrhage
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US7344512B2 (en) * 2002-03-15 2008-03-18 Sun Medical Technology Research Corporation Protector and blood pump system
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
EP1545636B1 (en) * 2002-09-10 2015-01-07 The American National Red Cross Hemostatic dressing
EP1563856A4 (en) * 2002-11-14 2008-02-27 Chemo Sero Therapeut Res Inst THROMBIN WEARING BIOABSORBABLE SYNTHETIC FILLERS
CA2509914A1 (en) * 2002-12-11 2004-06-24 Ferrosan A/S Gelatine-based materials as swabs
US7048914B2 (en) * 2002-12-12 2006-05-23 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
US20040124564A1 (en) * 2002-12-30 2004-07-01 Noorjahan Sheik Eusuff Process for preparing a chemically modified fibrin-fibrillar protein (FFP) composite sheet
US20060051340A1 (en) * 2003-01-20 2006-03-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Hemostatic materials
US20100248329A1 (en) * 2003-04-25 2010-09-30 Ryusuke Okamoto Blood coagulation promoter and blood collection tube
US20040243044A1 (en) * 2003-06-02 2004-12-02 Penegor Stephen A. Hemostatic wound dressing
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7179242B2 (en) 2003-08-01 2007-02-20 Belzidsky Hugues C Method of treating deep vein thrombosis
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7374754B2 (en) * 2003-09-02 2008-05-20 Essential Skincare, Llc Use of placental alkaline phosphatase to promote skin cell proliferation
US20050089551A1 (en) * 2003-10-22 2005-04-28 Recupero Elizabeth A. Clotting agent-containing window dressing
JP2007519450A (ja) * 2004-01-30 2007-07-19 フェロサン アー／エス 止血用のスプレーおよび組成物
US20060008505A1 (en) * 2004-07-08 2006-01-12 Brandon Gerard J Product
EP1786480B1 (en) * 2004-07-09 2016-09-21 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
US20090227930A1 (en) * 2004-07-15 2009-09-10 Crisp William E Hygiene materials and absorbents
US20100069813A1 (en) * 2004-07-15 2010-03-18 Crisp William E Wound dressings
US7495146B2 (en) * 2004-07-15 2009-02-24 Vivo Ltd. Partnership Wound dressing
WO2006021584A2 (en) * 2004-08-27 2006-03-02 Novo Nordisk Health Care Ag Purification of factor xiii polypeptides from biological materials
DK1809342T3 (en) * 2004-10-20 2015-08-17 Ethicon Inc absorbable hemostat
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
US8461302B2 (en) * 2004-11-23 2013-06-11 Zymogenetics, Inc. Purification of recombinant human factor XIII
EP1965830B1 (en) * 2005-12-28 2014-05-14 Zoltan Laboratories Llc Use of alkaline phosphatase to maintain healthy tissue mass in mammals
WO2007127390A2 (en) * 2006-04-28 2007-11-08 Biolife, L.L.C. Materials and methods for wound treatment
CA2651941C (en) * 2006-05-31 2015-02-17 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
CA2659936C (en) * 2006-08-04 2014-12-09 Martin Macphee Solid dressing for treating wounded tissue
US20090075891A1 (en) * 2007-08-06 2009-03-19 Macphee Martin Methods and dressings for sealing internal injuries
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
US20100285102A1 (en) * 2008-01-16 2010-11-11 Samuel Angel Colloidal collagen burn wound dressing produced from jellyfish
RU2545810C2 (ru) * 2008-02-29 2015-04-10 Ферросан Медикал Дивайсиз А/С Устройство для ускорения остановки кровотечения и/или заживления ран
AU2009220808B2 (en) 2008-03-03 2014-01-16 Omrix Biopharmaceuticals Ltd. A gelatin sponge comprising an active ingredient, its preparation and use
CA2721335A1 (en) * 2008-04-16 2009-10-22 Ryoichi Kawamura Process for preparing bioabsorbable sheet preparation holding thrombin
US8517979B2 (en) * 2008-12-22 2013-08-27 Abbott Laboratories Carriers for hemostatic tract treatment
US8110208B1 (en) 2009-03-30 2012-02-07 Biolife, L.L.C. Hemostatic compositions for arresting blood flow from an open wound or surgical site
US9039783B2 (en) * 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
US9162006B2 (en) * 2009-06-16 2015-10-20 Baxter International Inc. Hemostatic sponge
MX2012007056A (es) 2009-12-16 2012-09-28 Baxter Healthcare Sa Esponja hemostatica.
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
WO2011140021A1 (en) 2010-05-03 2011-11-10 Brightsource Industries (Israel) Ltd. Systems, methods, and devices for operating a solar thermal electricity generating system
DK2566334T3 (en) 2010-05-05 2018-07-23 Prolynx Llc MANAGED PHARMACEUTICAL RELEASE FROM SOLID CARRIERS
MX352875B (es) 2010-06-01 2017-12-13 Baxter Healthcare Sa Proceso para elaborar composiciones hemostaticas secas y estables.
BR112012030463B1 (pt) 2010-06-01 2021-08-24 Baxter International Inc. Processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, kit para administrar uma composição hemostática, e, grânulos revestidos com trombina
EP2575775B1 (en) 2010-06-01 2018-04-04 Baxter International Inc. Process for making dry and stable hemostatic compositions
US8715719B2 (en) 2010-06-16 2014-05-06 Abbott Vascular, Inc. Stable chitosan hemostatic implant and methods of manufacture
US10231721B2 (en) 2010-06-24 2019-03-19 St. Croix Surgical Systems, Llc Failsafe percutaneous wound barrier
CN103957949B (zh) 2011-10-11 2017-07-18 巴克斯特国际公司 止血组合物
JP6195568B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
AU2012330450B2 (en) 2011-10-27 2017-04-27 Baxter Healthcare Sa Hemostatic compositions
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
CN104349797B (zh) 2012-06-12 2017-10-27 弗罗桑医疗设备公司 干止血组合物
US9579388B2 (en) 2012-11-29 2017-02-28 Rene Gauthier System and method for alleviating the appearance of scars and/or scar tissue
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
IL229645A0 (en) 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin
CA2928963C (en) 2013-12-11 2020-10-27 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
WO2016058612A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
RU2717356C2 (ru) 2015-07-03 2020-03-23 Ферросан Медикал Дивайсиз А/С Шприц для удерживания вакуума в состоянии хранения
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB704517A (en) * 1951-08-07 1954-02-24 Schering Ag Improvements relating to media for stopping the flow of blood
US4022203A (en) * 1976-01-22 1977-05-10 Win Ackley Treated patch for minor cuts

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533004A (en) * 1943-10-27 1950-12-05 John D Ferry Fibrin clots and methods for preparing the same
US2465357A (en) * 1944-08-14 1949-03-29 Upjohn Co Therapeutic sponge and method of making
US2512616A (en) * 1946-01-12 1950-06-27 Johnson & Johnson Hemostatic alginic surgical dressings
US2772999A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical compositions and dressings
US3249109A (en) * 1963-11-01 1966-05-03 Maeth Harry Topical dressing
US3419006A (en) * 1966-08-08 1968-12-31 Union Carbide Corp Novel dressing and use thereof
JPH04111170A (ja) * 1990-08-31 1992-04-13 Nec Corp 回路基板レイアウト設計装置

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB704517A (en) * 1951-08-07 1954-02-24 Schering Ag Improvements relating to media for stopping the flow of blood
US4022203A (en) * 1976-01-22 1977-05-10 Win Ackley Treated patch for minor cuts

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1972 *
CA1975 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448901A1 (fr) * 1979-02-15 1980-09-12 Immuno Ag Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle
FR2448900A1 (fr) * 1979-02-15 1980-09-12 Immuno Ag Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle
EP0023607A3 (en) * 1979-07-19 1981-04-15 Behringwerke Aktiengesellschaft Process for preparing a collagen solution, such a solution and its use
FR2485375A1 (fr) * 1980-06-30 1981-12-31 Applied Med Devices Composition coagulante utilisable comme pansement et utilisation sous forme de produit preconditionne
FR2500304A1 (fr) * 1981-02-24 1982-08-27 Human Oltoanyagtermelo Materiau de recouvrement de plaie et son procede de fabrication
EP0090997A3 (en) * 1982-04-02 1985-10-30 Dr. Ruhland Nachf. Gmbh Adhesive wound covering material comprising collagen
EP0172710A3 (en) * 1984-08-09 1987-08-12 Unitika Ltd. Hemostatic agent
WO1990013320A1 (en) * 1989-05-05 1990-11-15 Ferrosan A/S Haemostatic sponge
EP0509041A4 (en) * 1990-01-03 1993-10-13 Cryolife, Inc Fibrin sealant delivery method
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
WO1994022470A1 (en) * 1993-03-30 1994-10-13 Hoechst Japan Limited Factor xiii for treatment of skin wounds

Also Published As

Publication number Publication date
DE2914822C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-06-01
DE2914822A1 (de) 1979-10-18
FR2422407B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-12-17
US4265233A (en) 1981-05-05
GB2023614B (en) 1982-08-04
GB2023614A (en) 1980-01-03

Similar Documents

Publication Publication Date Title
FR2422407A1 (fr) Matiere cicatrisante facilitant la cicatrisation des blessures
DE68927835D1 (de) Ultraschallbehandlung von Tieren
ES494933A0 (es) Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa.
BE858031A (fr) Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain
NO166232C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansyrer.
NO168353C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2'-aminofenyl)-benzamidderivater
DE3587741D1 (de) Behandlung von Hautkrankheiten.
NO893637D0 (no) Fremgangsmaate for aa stabilisere blodkoagulasjonsfaktorer.
ATE100320T1 (de) Verwendung von thromboxan-a2-rezeptorantagonisten zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von hautkrankheiten.
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
IT9041529A1 (it) Dispositivo per la correzione chirurgica dell'ametropia.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
DE69024382D1 (de) Fledermausspeichel-Plasminogenaktivator vPA-alpha 1
NO874892D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
ES486698A0 (es) Mejoras introducidas en la fabricacion de suturas quirurgi- cas elastomericas
BE883186A (fr) Fraise chirurgie dentaire
FR2595243B3 (fr) Couteau pour la chirurgie du segment anterieur de l'oeil
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
FR2636528B1 (fr) Composition capillaire pour la regeneration du derme humain ou animal
DK0499679T3 (da) Terapeutisk middel til diabetisk gangræn
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
DE3667518D1 (de) Behandlung von archivmaterial.
FI880891A7 (fi) Humaanikudoksen plasminogeenin rekombinanttiaktivaattorin koostumus.
ES542364A0 (es) "procedimiento de subirrigacion automatica de cultivos hi- droponicos".